Taken together, the results showed that the PI3Kα inhibitor combined with the EZH2 inhibitor synergistically suppressed the proliferation of ESCC cells by transcriptionally activating CDKN1A and inhibiting RB phosphorylation. The gene discussed is EZH2; the disease is esophageal squamous cell carcinoma.